Study details
Enrolling now
Carboplatin Chemotherapy Before Surgery for High-Risk Prostate Cancer
SWOG Cancer Research Network
NCT IDNCT05806515ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
44
Study length
about 7.3 years
Ages
18+
Sex
Male only
Locations
133 sites in AK, AZ, CA +16
What this study is about
This trial is testing if giving carboplatin chemotherapy before surgery helps treat high-risk prostate cancer patients with BRCA1 or BRCA2 gene mutations. Carboplatin is a type of platinum-containing drug that can shrink tumors, potentially improving outcomes.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Carboplatin
- 2.Undergo Biospecimen Collection
- 3.Undergo Chest Radiography
- +3 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
carboplatin
Procedures
diagnostic, imaging, surgery
Body systems
Oncology